ロード中...
Hepatic inflammation and progressive liver fibrosis in chronic liver disease
Chronic liver inflammation drives hepatic fibrosis, and current immunosuppressive, anti-inflammatory, and anti-viral therapies can weaken this driver. Hepatic fibrosis is reversed, stabilized, or prevented in 57%-79% of patients by conventional treatment regimens, mainly by their anti-inflammatory a...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Co., Limited
2014
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3949261/ https://ncbi.nlm.nih.gov/pubmed/24627588 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i10.2515 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|